Your session is about to expire
← Back to Search
Memsorb for Anesthesia Management (memsorb Trial)
memsorb Trial Summary
This trialshows the drawbacks of chemical CO2 absorbers: they create harmful compounds, increasing cost and environmental impact, & require daily disposal of special waste. Sustainable management of anesthesia is a growing concern.
memsorb Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowmemsorb Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.memsorb Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for an emergency surgery.I have a diagnosed respiratory condition like COPD or severe asthma.I speak English.
- Group 1: memsorb
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current size of participation for this investigation?
"Affirmative. Based on the clinical trial information hosted by clinicaltrials.gov, this medical study is actively enlisting participants. The research project was first shared online on January 1st 2017 and had its most recent update on November 18th 2022. 450 individuals need to be recruited from a single centre for the experiment to move forward as planned."
Is this research project currently seeking volunteer participants?
"Affirmative. Clinicaltrials.gov points to this research investigation actively seeking patients, which was initially publicized on January 1st 2017. The most recent update is from November 18th 2022 and 450 individuals are needed from a single clinical centre."
Share this study with friends
Copy Link
Messenger